GST NO. : 27AEZFS4094K1ZY
| Business Type | Exporter, Supplier, Trader |
| Packaging Type | Box |
| Packaging Size | 40 Capsules |
| Form | Capsules |
| Click to view more | |
Product Details
Usage
Treatment Of Mild To Moderate COVID-19
Active Ingredient
Molnupiravir
Drug Class
Antiviral
Administration
Oral, As Prescribed By A Doctor
Strength
200mg
Precaution
Not Recommended For Pregnant Women, Liver/kidney Disease Patients
Storage
Store At Room Temperature, Away From Moisture And Light
Product Description
- Indication: Treatment of mild to moderate COVID-19
- Active Ingredient: Molnupiravir 200mg
- Drug Class: Antiviral
- Administration: Oral, as prescribed by a doctor
- Side Effects: Headache, nausea, dizziness
- Precaution: Not recommended for pregnant women, liver/kidney disease patients
- Storage: Store at room temperature, away from moisture and light
- Molnunat 200mg contains Molnupiravir, an oral antiviral medication used for the treatment of mild to moderate COVID-19 in high-risk adults to prevent severe illness and hospitalization. It works by inhibiting viral replication, reducing the spread of the virus in the body. Manufactured by Natco Pharma Ltd, Molnunat 200mg comes in 40-capsule packaging and should be taken as prescribed by a doctor. Common side effects include headache, nausea, and dizziness. This medication is not a substitute for vaccination and should be used only under medical supervision. Not recommended for pregnant women or individuals with severe liver or kidney disease.
Looking for "Molnunat 200mg Molnupiravir Capsules" ?
Box
